Table 2.

Clinical findings in patients with quantitative MDPV concentrations

Patient no.	Urine (ng/mL)	Blood (ng/mL)	Clinical findings
1	3100	N/Aa	Sympathomimetic, intubated secondary to agitation, 12 days of ICU hospitalization
2	120	89	Sympathomimetic, intubated secondary to agitation, rhabdomyolysis and myocardial infarction, 20 days of hospitalization
3	1000	N/A	Somnolence, 1 day of ICU hospitalization
4	670	82	Sympathomimetic, intubated after cardiac arrest, 2 days of ICU hospitalization, death
5	2400	72	Sympathomimetic, 2 days of hospitalization with 1 day in ICU
6	509	<10	Sympathomimetic, SVT, 2 days of hospitalization with 1 day in ICU

N/A^a = not obtained